Feed AXIM
AX

AXIM Biotechnologies, Inc. AXIM OTC · Healthcare · United States

$0.00 +0.00% +$0.00

Market cap
$1.06M
Enterprise value
$8.83M
P/E
-
Forward P/E
-
PEG
-
P/S
2.7x
P/FCF
1.5x
EV/EBITDA
-
ROIC
36.8%
Gross margin
-8.7%
Net margin
-208.8%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
-0.11
Free float
71.6%

Sector

Healthcare

Industry

Biotechnology

CEO

Catalina Valencia

Employees

7

Headquarters

San Diego

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: It earns 37 USD a year on every 100 USD of invested capital.
  • What speaks for it: Out of every 100 USD of revenue, 180 USD is left as free cash.
  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: For every 100 USD of bills due within a year it has 0.2 USD of short-term assets.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy